iRhythm Technologies Inc
NASDAQ:IRTC

Watchlist Manager
iRhythm Technologies Inc Logo
iRhythm Technologies Inc
NASDAQ:IRTC
Watchlist
Price: 89.37 USD 0.8% Market Closed
Market Cap: 2.8B USD
Have any thoughts about
iRhythm Technologies Inc?
Write Note

iRhythm Technologies Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

iRhythm Technologies Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
iRhythm Technologies Inc
NASDAQ:IRTC
Operating Income
-$105m
CAGR 3-Years
-11%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$7B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
No Stocks Found

iRhythm Technologies Inc
Glance View

Market Cap
2.8B USD
Industry
Health Care

In the bustling realm of healthcare technology, where innovation meets necessity, iRhythm Technologies Inc. stands as a pivotal player, translating sophisticated algorithms into tangible, life-saving insights. Founded with the mission to redefine how cardiac care is delivered, iRhythm has pioneered its niche through the Zio platform—a sophisticated, wearable patch that monitors heart rhythms with precision. The Zio's elegant design belies its robust function, offering patients the comfort of continuous monitoring while living their daily lives. It gleans crucial data that is then transmitted to iRhythm's cloud-based platform, where advanced data analytics work tirelessly to think like a seasoned cardiologist, initially parsing through millions of heartbeats to identity potential abnormalities. As healthcare systems worldwide grapple with increasing demands and complexities, iRhythm's business model resonates well with the need for efficiency and effectiveness. The company generates revenue primarily through its patient-centric monitoring services, catering to healthcare providers who seek reliable diagnostic solutions. By billing insurers and healthcare institutions for the analytic results derived from the Zio patch, iRhythm seamlessly integrates into the cardiac care continuum. The blend of cutting-edge technology and strategic partnerships with healthcare providers not only fuels iRhythm's growth but also underscores a broader shift towards personalized and preventive medicine in cardiac care, demonstrating how strategic foresight can align with technical innovation to meet pressing healthcare challenges.

IRTC Intrinsic Value
55.54 USD
Overvaluation 38%
Intrinsic Value
Price

See Also

What is iRhythm Technologies Inc's Operating Income?
Operating Income
-105m USD

Based on the financial report for Sep 30, 2024, iRhythm Technologies Inc's Operating Income amounts to -105m USD.

What is iRhythm Technologies Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-14%

Over the last year, the Operating Income growth was 2%. The average annual Operating Income growth rates for iRhythm Technologies Inc have been -11% over the past three years , -14% over the past five years .

Back to Top